502 reports of this reaction
1.7% of all MERCAPTOPURINE reports
#13 most reported adverse reaction
CROHN^S DISEASE is the #13 most commonly reported adverse reaction for MERCAPTOPURINE, manufactured by Florida Pharmaceutical Products, LLC. There are 502 FDA adverse event reports linking MERCAPTOPURINE to CROHN^S DISEASE. This represents approximately 1.7% of all 30,320 adverse event reports for this drug.
Patients taking MERCAPTOPURINE who experience crohn^s disease should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
CROHN^S DISEASE is a less commonly reported adverse event for MERCAPTOPURINE, but still significant enough to appear in the safety profile.
In addition to crohn^s disease, the following adverse reactions have been reported for MERCAPTOPURINE:
The following drugs have also been linked to crohn^s disease in FDA adverse event reports:
CROHN^S DISEASE has been reported as an adverse event in 502 FDA reports for MERCAPTOPURINE. This does not prove causation, but indicates an association observed in post-market surveillance data.
CROHN^S DISEASE accounts for approximately 1.7% of all adverse event reports for MERCAPTOPURINE, making it a notable side effect.
If you experience crohn^s disease while taking MERCAPTOPURINE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.